Jardiance Tablets
Branded Jardiance Tablets (Empagliflozin Tablets) available in Australia, USA, UK, Philippines, New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, Sydney, Melbourne, Brisbane, Perth, Adelaide, Canberra, London, Birmingham, Manchester, Liverpool, Leeds, Glasgow, Edinburgh, Quezon City, Manila, Davao City , San Jose for hospitals, distributors, and export buyers. GMP-certified supplied across world with global shipping.
@SkyHighMedex
For bulk quotations, availability, and orders, please contact us:
📧 Email: skyhighmedex@gmail.com
🌐 www.skyhighmedexx.com
Himanshu Tolani: WhatsApp link https://wa.me/917276052731
📲 WhatsApp: +91 72760 52731
🌐 Why Choose Sky High Medex
💠 ISO Certified Exporter
💠 10+ Years of Global Pharma Export Experience
💠 Private Label & OEM Supply Options
💠 Complete Regulatory Documentation (COA, COPP, COO, )
💠 Temperature-Controlled International Logistics via DHL, FedEx & Arame
💳 Payment & Logistics
💱 Accepted Payment Modes: TT (Telegraphic Transfer), LC, PayPal, Bank Transfer
📞 Contact for Bulk Orders & Price Quotations
Sky High Medex
📧 Email: skyhighmedex@gmail.com
Product Introduction
SALT COMPOSITION: Empagliflozin (10mg / 25mg)
Dosage Form: Tablet (For Oral Use Only)
Storage: Store below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.
Jardiance Tablet (Empagliflozin 10mg or 25mg) is an oral antidiabetic medication from the SGLT2 inhibitor class. It helps lower blood sugar levels in adults with type 2 diabetes by promoting glucose excretion through urine. Beyond glycemic control, Jardiance offers proven cardiovascular and renal protection, reducing the risk of heart failure and kidney disease progression in diabetic and non-diabetic patients alike.
The tablet should be taken once daily, with or without food, as directed by a healthcare professional. Dosage is individualized based on glycemic targets and clinical response.
Uses of Jardiance Tablet
Management of Type 2 Diabetes Mellitus
Reduction of cardiovascular mortality in adults with type 2 diabetes and established heart disease
Heart failure treatment (with reduced or preserved ejection fraction)
Chronic kidney disease (CKD) management to delay disease progression and reduce hospitalization
Benefits of Jardiance Tablet
Jardiance provides comprehensive metabolic, cardiac, and renal benefits:
Effectively lowers blood glucose by increasing urinary glucose excretion
Reduces cardiovascular death in patients with type 2 diabetes and heart disease
Promotes weight loss and modest blood pressure reduction
Helps preserve kidney function and delay dialysis need
Works independently of insulin, complementing other antidiabetic agents
How Jardiance Tablet Works
Empagliflozin, the active component of Jardiance, selectively inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, which is responsible for glucose reabsorption into the bloodstream.
By blocking SGLT2, Jardiance increases glucose elimination through urine (glycosuria), resulting in lower blood sugar levels, reduced calorie load, and osmotic diuresis.
This dual action contributes to improved glycemic control, weight reduction, and cardiovascular protection.
Side Effects
Common side effects:
Increased urination or thirst
Genital or urinary tract infections
Dehydration or dizziness
Mild drop in blood pressure
Serious but rare side effects:
Diabetic ketoacidosis (may occur even with normal glucose levels)
Severe urinary tract infections
Hypoglycemia (especially when combined with insulin or sulfonylureas)
Kidney function changes (usually reversible)
Safety Advice
Alcohol: Avoid excessive consumption; may increase dehydration or ketoacidosis risk.
Pregnancy & Breastfeeding: Not recommended during pregnancy or lactation.
Kidney/Liver: Use with caution; monitor renal function regularly.
Hydration: Ensure adequate fluid intake to prevent dehydration.
Medical Supervision: Use only under a qualified physician’s guidance with periodic monitoring of glucose, kidney function, and cardiovascular health.
